ClinicalTrials.gg
RecruitingNCT05780021EMOTIVUpdated Aug 22, 2025

Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation

An interventional study of Motivational Support Program Emotiv in Chronic Low-back Pain, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in Low Back Pain by Assistance Publique - Hôpitaux de Paris — 9 open to participants now, 9 under way, 3 of them phase 3. Low Back Pain · Assistance Publique - Hôpitaux de Paris.

Planned enrollment
7th of 17
150 · median 130
Started
2023
with 1 other
No phase
12 of 20
6 open now
Registered
14th of 20
by date

Among the 20 studies in Low Back Pain by Assistance Publique - Hôpitaux de Paris, this one is the 7th largest by planned enrollment of the 17 interventional ones that give a count, is one of 2 that started in 2023, is one of 12 with no phase, and was the 14th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

9 of the 20 studies in Low Back Pain by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Low Back Pain by Assistance Publique - Hôpitaux de Paris, or all of them as a file.
02

Study summary

Chronic low back pain (CLBP) is a major public health problem. Multidisciplinary functional rehabilitation program (FRP), which give patients the skills to better manage pain and return to physical activity, are effective in the short term. In the medium and long term, due to lack of motivation, two thirds of patients stop their physical activity again, causing them to fall back into the vicious circle of pain. Investigators hypothesise that a remote assessment and motivational support program (MSP) based on an application, piloted by a care coordinator, could allow the continued improvement of symptoms and activities observed after the FRP programs, and thus limit the consequences of CLBP for the patient and society. The main objective of this study is to evaluate the effect of the motivational support program EMOTIV, on disability and pain at one year, in chronic low back pain patients who have benefited from a FRP program.

Read the detailed description

Multidisciplinary functional rehabilitation program (FRP) have shown their efficacy in disabilitie patient suffering from Chronic low back pain (CLBP). Unfortunately, at medium and long term two thirds of patients stop their physical activity due to lack of motivation. These patients then fall back into their painful vicious circle. Investigators hypothesis that motivational support program (MSP) based on an application, piloted by a care coordinator could increase the motivation to continue physical activity and thus limit the consequences of CLBP for the patient and society. The main objective is to evaluate the impact of a MSP (EMOTIV) on pain and functional abilities assessed according to the COMI scale (Core Outcome Measure Index), 12 months after a FRP in patients with LPBC. This program is compared to usual care as currently done. The secondary criteria concern: physical, neuropsychological and medico-economical criteria. This is a multicentre, cluster randomized trial. All adult patient suffering from low back pain, having finished a FRP and possessing a smartphone, will be included. Investigators plan to include 150 patients in 6 centres. The duration of the inclusion period is 12 months; The duration of participation of each subject is 24 months. Inclusion will be on the last day of the FRP program. The Follow-up in consultation is scheduled at 3, 12 and 24 months with evaluation of usual criteria (physical, self-questionnaires, and advice on the practice of physical activities depending on what is achieved). In Pitie salpetriere center only, patients will have in addition: lumbar MRI at 3 and 12 months; central pain awareness assessment. The activity of patients in the MSP group will be recorded continuously par EMOTIV App; pain, mental health and days off every week and self-questionnaires at 1, 2 and 6 months. The primary analysis of all endpoints will be performed in the intent-to-treat population, i.e. all patients randomized to the study. The COMI score will be compared between the 2 randomized groups by a linear mixed model.

03

Conditions studied

  • Chronic Low-back Pain

Browse trials for

Keywords

  • Chronic Low-back Pain
  • Multidisciplinary function rehabilitation
  • Motivational Support Program Emotiv
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 18 or over
  • Disabling chronic low back pain: chronic painful patient, that is to say suffering from pain for more than 3 months, having interrupted all physical activity because of low back pain and have an indication for a FRP for low back pain.
  • Having reached the end of an FRP program
  • Possession of a smartphone
  • Fluency in French (writing, reading)
  • Health insurance coverage (beneficiary or beneficiary) except State Medical Aid.
  • Patient Signature

Exclusion criteria

Exclusion Criteria:

  • Pregnant woman
  • Patient refusal
  • Patient deprived of liberty and patient under legal protection measure (guardianship, guardianship)
  • Patient participating to another interventional search
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • No intervention
    Standard arm

    The patients will have the usual care

  • Experimental
    Motivational Support Program Emotiv

    The patients will have the motivational support program

    Behavioral: Motivational Support Program Emotiv

Interventions

  • BehavioralMotivational Support Program Emotiv

    A motivational support program including a motivational and self-assessment remote application in the form of a Smartphone application for chronic low back pain patients after multidisciplinary functional rehabilitation.

06

What researchers measure

Primary outcomes

  1. Difference in disability and pain between the experimental (SHP) and control (usual care) groups, measured with the Core Outcome Measure Index (COMI) scale at 12 months.

    The Core Outcome Measure Index (COMI) was developed from requirements of international back pain experts. According to European experts, the COMI should currently be recommended in assessment of chronic low back pain. This questionnaire assesses pain and disability in low back pain. It includes 9 items and its score is between 0 and 10. Higher scores is the worse outcome.

    Time frame: 12 months after completion of the multidisciplinary functional rehabilitation program

Secondary outcomes

  1. Evolution of pain

    Pain will be measured by a Visual Analogic Scale (VAS) with a question about lumbar pain over the last 7 days. Minimum and maximum values are 0 and 100.

    Time frame: At 3 months, 12 months and 24 months

  2. Evolution of flexibility

    Flexibility will be evaluated by measuring the hand-to-ground distance

    Time frame: At 3 months, 12 months and 24 months

  3. Evolution of muscular endurance

    Muscular endurance will be assessed by measuring Shirado (abdominal endurance). Its score is between 0 and no limit. 0 is the worse outcome.

    Time frame: At 3 months, 12 months and 24 months

  4. Evolution of muscular endurance

    Muscular endurance will be assessed by measuring Sorensen (spinal extensor endurance). Its score is between 0 and no limit. 0 is the worse outcome.

    Time frame: At 3 months, 12 months and 24 months

  5. Evolution of disability and pain

    Disability and pain will be assessed by the Core Outcome Measure Index (COMI) questionnaire. Its score is between 0 and 10. Higher scores is the worse outcome.

    Time frame: At 3 months, 12 months and 24 months

  6. Evolution of endurance and sports performance (VO2 max)

    Endurance and sports performance will be assessed on the treadmill

    Time frame: At 3 months, 12 months and 24 months

  7. Evolution of the intensity of physical activity

    Intensity of physical activity will be assessed by the IPAQ (International Physical Activity Questionnaire). Scoring a high level of physical activity on the IPAQ means the physical activity levels equate to approximately one hour of activity per day or more at least a moderate intensity activity level.

    Time frame: At 3 months, 12 months and 24 months

  8. Evolution of muscular trophicity in the 2 groups

    Muscular trophicity will be done by the measurement of the cross-sectional area (CSA) of the extensor muscles at the level of the upper and lower plateaus of L4 at the lumbar spine

    Time frame: At 3 months and 12 months

  9. Evolution of the level of anxiety and depression

    Level of anxiety and depression will be assessed by the HAD (Hospital Anxiety and Depression) scale. 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus allowing two scores (maximum and worse of each score equal 21)

    Time frame: At 3 months, 12 months and 24 months

  10. Evolution of the level of central pain awareness

    Two parameters will be used, in accordance with international recommendations on Quantitative Sensory Testings : the pain pressure threshold using an algometer, at a distance from the painful area (forearm), and the temporal summation by repeating a painful stimulus with a calibrated needle (PinPrick)

    Time frame: At inclusion, 3 months, 12 months and 24 months

  11. Medico-economic analysis

    The elements for the medico-economic analysis will be collected on the basis of a questionnaire validated in French. The data collected are : - consultations in general medicine and rheumatology as part of the usual follow-up of patients, - biological or imaging examinations carried out for the spinal problem, - medicinal treatments (drugs, infiltrative procedures) and non-medicinal treatments (physiotherapy, others) carried out for the spinal problem, - any hospitalizations related to the spinal problem

    Time frame: At 3 months, 12 months and 24 months

  12. Cost of care (i.e, health resource use and related costs or direct costs)

    Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued on the basis of the tariffs of the National Health Insurance Fund (CNAM). Health resource use related costs will be expressed in Euros

    Time frame: At 3 months, 12 months and 24 months

  13. Cost of care (i.e, health resource use and related costs or direct costs)

    Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Common Classification of Medical Acts (CCAM). Health resource use related costs will be expressed in Euros

    Time frame: At 3 months, 12 months and 24 months

  14. Cost of care (i.e, health resource use and related costs or direct costs)

    Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the Nomenclature of Medical Biology Acts (NABM). Health resource use related costs will be expressed in Euros

    Time frame: At 3 months, 12 months and 24 months

  15. Cost of care (i.e, health resource use and related costs or direct costs)

    Health resource use will be quantified by the number of consultations, biologic and imaging workups, hospitalisations with their motives, and the list of treatments taken by the patients. It will be valued using data from the national scale of costs (ENC) for hospitalisations. Health resource use related costs will be expressed in Euros

    Time frame: At 3 months, 12 months and 24 months

  16. Sick leave days

    The number of working days off work will be elicited

    Time frame: At 3 months, 12 months and 24 months

  17. Productivity loss (i.e, sick leave-related costs or indirect costs)

    Sick leave days will be valued on the basis of the average daily salaries published each year by the French National Institute of Statistics (INSEE, www.insee.fr). It will be expressed in Euros.

    Time frame: At 3 months, 12 months and 24 months

  18. Satisfaction with the program

    Satisfaction with the program will be measured by a Visual Analogic Scale (VAS). Minimum and maximum values are 0 and 100. The better score is 100.

    Time frame: At 3 months, 12 months and 24 months

  19. Adherence to the program

    Adherence to the program will be evaluated on the number of connection (minimum value 0 and no maximum)

    Time frame: At 3 months, 12 months and 24 months

  20. Adherence to the program

    Adherence to the program will be evaluated on the time of connection (minimum value 0 and no maximum)

    Time frame: At 3 months, 12 months and 24 months

  21. Adherence to the program

    Adherence to the program will be evaluated on number of reminders necessary by the coordinator in case of non connection and/or non attendance at the follow-up (minimum value 0 and non maximum)

    Time frame: At 3 months, 12 months and 24 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The procedures carried out with the French data privacy authority (CNIL, Commission nationale de l'informatique et des libertés) do not provide for the transmission of the database, nor do the information and consent documents signed by the patients. Consultation by the editorial board or interested researchers of individual participant data that underlie the results reported in the article after deidentification may nevertheless be considered, subject to prior determination of the terms and conditions of such consultation and in respect for compliance with the applicable regulations.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Beginning 3 months and ending 3 years following article publication. Requests out of these time frame can also be submitted to the sponsor

Access criteria: Researchers who provide a methodologically sound proposal.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Sep 2025, 24 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 24 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2023
First posted
Mar 22, 2023
StartActual
Sep 26, 2023
Primary completionEst.
Sep 26, 2025
CompletionEst.
Sep 26, 2026
Last update
Aug 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05780021
Responsible party
Sponsor
First posted
Mar 22, 2023
Start date
Sep 26, 2023
Primary completion
Sep 26, 2025 (estimated)
Completion
Sep 26, 2026 (estimated)
Last update
Aug 22, 2025

Study contacts

Violaine FOLTZ, Dr
Contact
violaine.foltz@aphp.fr
01 42 17 79 58
Bruno FAUTREL, Pr
Contact
bruno.fautrel@aphp.fr
01 42 17 78 01
Violaine FOLTZ, Dr
principal investigator · Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion